Latest News about MRK
Recent news which mentions MRK
   Unpacking the Latest Options Trading Trends in Merck & Co
   
  January 07, 2025
  Tickers 
   MRK
  
  
  From Benzinga
 From Benzinga
 
   Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
   
  
  
  January 06, 2025
  From Benzinga
 
   Why Viking Therapeutics Stock Plummeted by 24% in December
   
  
  
  January 04, 2025
  From Motley Fool
 
   Should You Buy the Dip on This High-Flying Stock?
   
  
  
  January 03, 2025
  From Motley Fool
 
   UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
   
  
  
  January 02, 2025
  From Benzinga
 From Benzinga
 
   2 High-Yield Dividend Stocks to Buy Early in 2025
   
  
  
  December 31, 2024
  From Motley Fool
 
   Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
   
  
  
  December 30, 2024
  From Motley Fool
 
   3 Stocks That Could Be Monster Winners in 2025
   
  
  
  December 29, 2024
  From Motley Fool
 
   Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
   
  
  
  December 25, 2024
  From Benzinga
 
   Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
   
  
  
  December 22, 2024
  From Benzinga
 
   Is Merck the Next Big Weight-Loss Stock?
   
  
  
  December 22, 2024
  From Motley Fool
 
   Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
   
  
  
  December 21, 2024
  From Motley Fool
 
   Why Viking Therapeutics Tumbled by More Than 10% This Week
   
  
  
  December 20, 2024
  From Motley Fool
 
   Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks
   
  
  
  December 20, 2024
  From Motley Fool
 
   3 Stocks That Could Turn $1,000 into $5,000 by 2030
   
  
  
  December 20, 2024
  From Motley Fool
 
   Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
   
  
  
  December 19, 2024
  From Benzinga
 
   Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
   
  
  
  December 19, 2024
  From Benzinga
 
   Stock Of The Day: Where Does The Merck Downtrend End?
   
  
  
  December 19, 2024
  From Benzinga
 
   Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
   
  
  
  December 18, 2024
  From Benzinga
 
   What's Going On With Viking Therapeutics Stock On Wednesday?
   
  
  
  December 18, 2024
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  December 18, 2024
  From Benzinga
 
   What's Going On With Merck Shares Wednesday?
   
  
  
  December 18, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
   
  
  
  December 13, 2024
  From Benzinga
 
   These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
   
  
  
  December 12, 2024
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.